Becton Dickinson (BDX) stock forecast for 2022
Last update: September 24, 2022 (10:39)Sector: Healthcare
The share price of Becton Dickinson and Company (BDX) now
What analysts predict:: $278.27
52-week high/low: $275.43 / $226.31
50/200 Day Moving Average: $251.96 / $253.32
This figure corresponds to the average price over the previous 50/200 days. For Becton Dickinson stocks, the 50-day moving average is the support level today.
For Becton Dickinson stocks, the 200-day moving average is the resistance level today.
Are you interested in Becton Dickinson stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Becton Dickinson stock price in 2022. How much will one Becton Dickinson share be worth in 2022?
Is it worth taking profit / loss on Becton Dickinson stock now or waiting? What are analysts' forecasts for Becton Dickinson stock?
We forecast Becton Dickinson stock performance using neural networks based on historical data on Becton Dickinson stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
The Becton Dickinson stock prediction results are shown below and presented as a graph, table and text information.
Becton Dickinson stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Becton Dickinson analysts is $278.27.
Today 200 Day Moving Average is the resistance level (253.32 $).
50 Day Moving Average is the support level (251.96 $).
Historical and forecast chart of Becton Dickinson stock
The chart below shows the historical price of Becton Dickinson stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Becton Dickinson stock price can be found in the table below.
Becton Dickinson (BDX) Forecast for 2022
Becton Dickinson information and performance
Becton Dickinson is a medical company that manufactures and markets medical devices, instruments and reagents. Becton Dickinson’s clients are hospitals, clinics, laboratories and pharmaceutical companies. The company operates in three areas: medicine, diagnostics and research.
Becton Dickinson is included in the Fortune 500 – the rating of the largest US companies according to the Fortune magazine. Works in 50 countries. The company employs 49.5 thousand employees. In 2015, Becton Dickinson earned $ 10.3 billion.
Maxwell Beckton and Fairleigh Dickinson founded the company in 1897. They originally sold glass syringes for $ 2.50 each. In 1898, the company bought its first patent. Since 1954, Becton Dickinson began to massively sell disposable syringes – until that moment they were not on sale.
Becton Dickinson Address
ONE BECTON DR, FRANKLIN LAKES, NJ, US
Market Capitalization: 67 879 264 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: 5 456 000 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: 36.17
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: 3.384
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: -0.318
Quarterly Revenue Growth YOY: 0.007
Trailing PE: 36.17
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: 19.3
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 4.155
Enterprise Value (EV) /Revenue
EV To EBITDA: 17.23
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 285195000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Becton Dickinson price target for 2021 by month
Target values for the price of one Becton Dickinson share for Oct 2022.
Pessimistic target level: 237.95
Optimistic target level: 259.35
Target values for the price of one Becton Dickinson share for Nov 2022.
Pessimistic target level: 235.13
Optimistic target level: 253.45
Target values for the price of one Becton Dickinson share for Dec 2022.
Pessimistic target level: 230.28
Optimistic target level: 258.65
Becton Dickinson (BDX) stock dividend
Becton Dickinson last paid dividends on 09/08/2022. The next scheduled payment will be on 09/30/2022. The amount of dividends is $3.44 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Last Split Factor:
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.